National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Genetics of Colorectal Cancer (PDQ®)
Health Professional VersionLast Modified: 09/23/2008
Table 7C. Summary of Studies Evaluating Interest in or Intention to Have Genetic Counseling and Testing for Familial Adenomatous Polyposis (FAP)a

Study Population   Nb  Interest or Intention in GC or GTc 
FAP-affected individuals [16] 25 60% prenatal GT interest; 18% would consider aborting fetus if mutation was found
FAP-affected individuals [17] 62 65% prenatal GT interest; 24% would consider aborting fetus if mutation was found; 94% GT interest at birth

aBoth studies used a cross-sectional design and were conducted in the United Kingdom.[16,17]
bIndicates number of participants older than 18 years, unless otherwise specified.
cType of genetic test not specified.

References

  1. Burn J, Chapman P, Delhanty J, et al.: The UK Northern region genetic register for familial adenomatous polyposis coli: use of age of onset, congenital hypertrophy of the retinal pigment epithelium, and DNA markers in risk calculations. J Med Genet 28 (5): 289-96, 1991.  [PUBMED Abstract]

  2. Whitelaw S, Northover JM, Hodgson SV: Attitudes to predictive DNA testing in familial adenomatous polyposis. J Med Genet 33 (7): 540-3, 1996.  [PUBMED Abstract]


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov